Navigation Links
DNDi is awarded USD 17.3 million from UNITAID to spur development and delivery of child-adapted ARVs
Date:12/11/2012

[Geneva, Switzerland, 11 December 2012] The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its paediatric HIV programme. The grant, to be disbursed over three years, will enable DNDi and partners to build on the advances made in the field of paediatric HIV to date, and drive specific research and development to deliver child-adapted ARV formulations that do not require refrigeration, are easy-to-administer and palatable, with simplified dosing, and which can be given to children co-infected with tuberculosis.

'This support from UNITAID is an encouraging sign that DNDi and our partners are on the right path, and we will stay focused in our efforts to ensure that adapted treatments reach the kids that need them', said Dr Bernard Pcoul, Executive Director of DNDi. 'Timely delivery, adoption, and uptake will be key to saving the lives of the youngest children with HIV/AIDS', he added.

DNDi entered into the field of paediatric HIV in 2011 and, earlier this year, announced a partnership agreement with the Indian drug manufacturer Cipla to develop adapted 4-in-1 ARV formulations for children with HIV/AIDS under three years of age.


'/>"/>

Contact: Violaine Dallenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative
Source:Eurekalert

Page: 1

Related medicine news :

1. Speech-language researcher awarded top honors
2. Boston Medical Center awarded elite distinction as a 2012 Leapfrog Top Hospital
3. Scripps Florida scientist awarded $2.5 million to study inner workings of memory formation
4. LSUHSCs Tilton awarded prestigious Hower Award
5. Vijay Tiwari awarded prestigious grant to study how cancer cells transform to become invasive
6. Kessler Foundation scientists awarded New Jersey grants for brain injury research
7. Einstein-Montefiore scientists awarded 2 NCI Provocative Questions grants
8. Illy Trieste Science Prize: Yuk Ming Dennis Lo awarded for non-invasive prenatal diagnosis
9. Nearly $50 million in research funding awarded by NSF
10. Cedars-Sinai Heart Institute awarded $1.3 million to study cardiac stem cells
11. Weill Cornell awarded $1.8 million for translational blood cancer research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... December 07, 2016 , ... The Cliff Hart ... in South Lyon, Dewitt, Williamston, East Lansing, Ann Arbor, and Farmington Hills, is ... for a brain tumor. , Jason Bauer and his family are longtime members ...
(Date:12/7/2016)... ... , ... A. Kevin Spann Insurance, a New York-based firm offering insurance and ... a charity drive to raise funds that will benefit the Marine Corps League. , ... Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann team plans ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and ... The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now ... the Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in ...
(Date:12/7/2016)... CINCINNATI, Ohio (PRWEB) , ... December 07, 2016 ... ... winner in the 2016 BOC Business Brilliance Awards under the Best New Product ... inception and results achieved through user experience. , BOC Global Events & Training ...
(Date:12/7/2016)... , ... December 07, 2016 , ... “Walking With God: ... stories that will inspire the reader to be aware of God's direction in their ... published author, Sanford Smith, retired teacher and active church leader. , Sanford ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... NESS ZIONA SCIENCE PARK , ... Israeli biotechnology company Kadimastem (TASE: KDST) announced today the signing of ... strategic collaboration between the companies. The synergy between the companies will ... Kadimastem-Corestem collaboration as a worldwide leader in innovative treatment for severe ... ...
(Date:12/7/2016)... December 7, 2016 According to a new market ... Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity ... Market is expected to reach USD 1,519.2 Million by 2021 from USD ... Continue Reading ... ...
(Date:12/7/2016)... LONDON , Dec. 7,2016  Based ... drug delivery industry, Frost & Sullivan recognizes ... Frost & Sullivan Award for Enabling Technology ... plug the loopholes in traditional drug delivery ... and liquid microneedle-based drug delivery technologies, Memspatch ...
Breaking Medicine Technology: